Cardinal Health Strikes $1.9 Billion Deal for Solaris Health
Cardinal Health, the global healthcare conglomerate, has made another large push into the healthcare provider space. On August 12, through its subsidiary The Specialty Alliance, Cardinal Health bought Solaris Health in a $1.9 billion deal, its fifth deal since the start of 2024. Solaris Health is one of the largest urology and management service organizations in the United States, with more member physicians than any other provider of urological and specialty services. Its physicians span 14 states (Colorado, Florida, Georgia, Illinois, Indiana, Kentucky, Maryland, Michigan, New York, North Carolina, Ohio, Pennsylvania, South Carolina and Washington), with more than 750... Read More »
Megadeals in Healthcare: A 2025 Mid-Year Review and Outlook
Healthcare megadeals, defined as transactions valued at $1 billion or more, slowed notably in the first half of 2025, according to data captured in the LevinPro database. There were 18 megadeals announced during the first half of 2025, a 33% decline from the 27 deals announced during the same period of 2024. The decline marks the lowest mid-year tally since 2020 and continues a downward trend from the 30 megadeals announced in the first half of 2022 and 19 in the first half of 2023. While the billion-dollar threshold was still crossed multiple times across the Biotechnology, Pharmaceutical, eHealth, Medical Devices and more sectors, the pace of activity suggests growing caution among... Read More »
Healthcare M&A Remained Steady in First Half of 2025
Healthcare merger and acquisition (M&A) activity remained nearly steady in the first half of 2025, with 1,020 deals announced, according to data from the LevinPro HC platform. This represents a slight decrease compared to 1,025 transactions announced in the first half of 2024. The difference in quarter-over-quarter activity was more pronounced in the second quarter of 2025, with 489 deals announced, marking an 8% drop from the 531 transactions in the first quarter of 2025, and a 4% decrease from the 511 deals in Q2:24. Disclosed spending in Q2:25 totaled $30 billion, a 55% decrease from $66.4 billion in Q1:25, and down 41% from $50.8 billion in Q2:24. For the first half of 2025,... Read More »
Market Uncertainty Takes its Toll on Healthcare M&A in Q2
Results from the healthcare M&A market reveal activity declined sharply in the second quarter of 2025. Volume reached approximately 479 deals so far, an 8% decrease from activity in the first quarter of 2025, when 523 deals were announced. Compared with the second quarter of 2024, results are down approximately 16% in Q2:25. Dealmakers and industry experts have hinted at this slowdown in the conversations we’ve had with them over the past few months. Market uncertainty is the number one headwind cited, ranging from shifting tariff and trade policies that harm hospital supply chains to looming Medicaid cuts and persistent interest rate challenges. There is also a wave of... Read More »
Healthcare Cuts in Trump’s “One, Big, Beautiful Bill”
After pulling an all-nighter, House Republicans narrowly passed a megabill to enact President Trump’s domestic agenda. The legislation, called the “One Big Beautiful Bill Act” (OBBBA), includes sweeping healthcare cuts, affecting Medicaid and Medicare. Key Healthcare Cuts & Changes in President Trump’s Bill The bill aims to cut at least $625 billion in federal Medicaid funding over the next 10 years, according to initial estimates by the Congressional Budget Office (CBO). Medicare could also experience cuts, due to rules surrounding the Pay-As-You-Go Act from 2010, which requires any spending to be offset by automatic cuts, to avoid deficit spending. According... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
